{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:38:48Z","timestamp":1759412328835},"reference-count":20,"publisher":"Elsevier BV","issue":"38","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:00Z","timestamp":1469664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR Biomedical Research Centre"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.vaccine.2016.07.050","type":"journal-article","created":{"date-parts":[[2016,7,31]],"date-time":"2016-07-31T09:17:24Z","timestamp":1469956644000},"page":"4470-4474","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses"],"prefix":"10.1016","volume":"34","author":[{"given":"Christine S.","family":"Rollier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian V.S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arturo","family":"Reyes-Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2016.07.050_b0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.coi.2011.03.006","article-title":"Viral vectors as vaccine platforms: deployment in sight","volume":"23","author":"Rollier","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2016.07.050_b0010","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1517\/14712598.2013.791277","article-title":"Ever closer to a prophylactic vaccine for HCV","volume":"13","author":"Swadling","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2016.07.050_b0015","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1016\/j.vaccine.2011.05.083","article-title":"Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines","volume":"29","author":"Pillai","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.050_b0020","first-page":"350","article-title":"Gene transfer into human dendritic antigen-presenting cells by vaccinia virus and adenovirus vectors","volume":"5","author":"Di Nicola","year":"1998","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.vaccine.2016.07.050_b0025","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0264-410X(01)00450-9","article-title":"Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes","volume":"20","author":"Gilbert","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.050_b0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.virol.2007.05.028","article-title":"Multiple immunizations with adenovirus and MVA vectors improve CD8+ T cell functionality and mucosal homing","volume":"367","author":"Tatsis","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.07.050_b0035","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.00740-09","article-title":"Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses","volume":"78","author":"Reyes-Sandoval","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2016.07.050_b0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.virol.2010.07.004","article-title":"Recombinant vector-induced HIV\/SIV-specific CD4+ T lymphocyte responses in rhesus monkeys","volume":"406","author":"Sun","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2016.07.050_b0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clim.2014.09.005","article-title":"Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques","volume":"155","author":"Valentin","year":"2014","journal-title":"Clin Immunol"},{"key":"10.1016\/j.vaccine.2016.07.050_b0050","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.4049\/jimmunol.1100302","article-title":"CD8+ T effector memory cells protect against liver-stage malaria","volume":"187","author":"Reyes-Sandoval","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.07.050_b0055","doi-asserted-by":"crossref","first-page":"e45840","DOI":"10.1371\/journal.pone.0045840","article-title":"Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens","volume":"7","author":"Ratto-Kim","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2016.07.050_b0060","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/mt.2008.141","article-title":"The immunogenicity of adenovirus vectors limits the multispecificity of CD8 T-cell responses to vector-encoded transgenic antigens","volume":"16","author":"Schirmbeck","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2016.07.050_b0065","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1038\/mt.2012.25","article-title":"Mixed vector immunization with recombinant adenovirus and MVA can improve vaccine efficacy while decreasing antivector immunity","volume":"20","author":"Reyes-Sandoval","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2016.07.050_b0070","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1084\/jem.20041912","article-title":"Identification of poxvirus CD8+ T cell determinants to enable rational design and characterization of smallpox vaccines","volume":"201","author":"Tscharke","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2016.07.050_b0075","doi-asserted-by":"crossref","first-page":"7193","DOI":"10.4049\/jimmunol.180.11.7193","article-title":"Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve","volume":"180","author":"Oseroff","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2016.07.050_b0080","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2016.07.050_b0085","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0264-410X(95)00032-V","article-title":"Adenovirus vectors as recombinant viral vaccines","volume":"13","author":"Imler","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.07.050_b0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12026-011-8204-3","article-title":"T cell recognition of weak ligands: roles of signaling, receptor number, and affinity","volume":"50","author":"Edwards","year":"2011","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2016.07.050_b0095","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1128\/JVI.02497-06","article-title":"Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors","volume":"81","author":"McCoy","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2016.07.050_b0100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1517\/14712598.2014.885946","article-title":"Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines","volume":"14","author":"Hanke","year":"2014","journal-title":"Expert Opin Biol Ther"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630648X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1630648X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T04:20:07Z","timestamp":1536553207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1630648X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":20,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0264410X1630648X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of adenovirus and MVA vaccines on the breadth and hierarchy of T cell responses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.07.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}